Efficacy and pharmacologic data of second-generation tyrosine kinase inhibitor nilotinib in BCR-ABL-positive leukemia patients with central nervous system relapse after allogeneic stem cell transplantation (Q30836557)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and pharmacologic data of second-generation tyrosine kinase inhibitor nilotinib in BCR-ABL-positive leukemia patients with central nervous system relapse after allogeneic stem cell transplantation |
scientific article |
Statements
1 reference
Efficacy and pharmacologic data of second-generation tyrosine kinase inhibitor nilotinib in BCR-ABL-positive leukemia patients with central nervous system relapse after allogeneic stem cell transplantation (English)
1 reference
1 reference
Eckhard Thiel
1 reference
Wolf-Karsten Hofmann
1 reference
Mark Reinwald
1 reference
Eberhard Schleyer
1 reference
Philipp Kiewe
1 reference
Igor Wolfgang Blau
1 reference
Stefan Pursche
1 reference
Martin Neumann
1 reference
Michael Notter
1 reference
Hans-Jochem Kolb
1 reference
Stefan Burdach
1 reference
15 June 2014
1 reference
1 reference
2014
1 reference
637059
1 reference
1 January 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference